Experic, which offers a range of development and manufacturing services for DPIs, has announced the appointment of former Catalent Drug Delivery Solutions General Manager Matthew Mollan as Chief Executive Officer. According to the company, previous CEO David Wood has retired after leading Experic since 2021.
Mollan was most recently VP, Operations, Early Phase at Catalent. Prior to joining Catalent in 2012, he held a number of leadership roles in formulation and development departments at Aptuit and at Pfizer (Parke Davis / Warner Lambert).
Experic Chairman of the Board commented, “Matthew brings the hands-on operational leadership and client-first mindset that aligns perfectly with Experic’s culture and ambitions. His experience scaling complex pharmaceutical manufacturing organizations and delivering consistent quality makes him exceptionally well suited to lead Experic into its next phase of growth.”
Mollan said, “I am honored to join Experic at such an exciting stage of its growth. The company has built a strong reputation for quality, flexibility, and partnership. I look forward to working with the talented Experic team to expand on our capabilities, deepen client relationships, and help our customers bring critical therapies to patients efficiently and reliably.”
Read the Experic press release
